The Board of ADDvise Group AB (publ) (\"ADDvise\" or the \"Company\")
has decided on a directed share issue to a small group of investors for
a total of 3,791,469 shares of series B, corresponding to approximately
14.4 percent of the total number of outstanding shares in the Company.
The subscription price amounts to 2.11 SEK per share. The share issue
increases the share capital by 3,791,469 SEK. The Issue provides the
company with approximately 8.0 million SEK before transaction costs.
The reason for deviation from the shareholders preferential rights and
the motives for the share issue is to finance the acquisition of LabRum
AB and broaden the shareholder base with qualified investors. The issue
increases the number of shares of series B in the Company by 3,791,469
shares. The company\'s total number of outstanding shares increases from
22,468,178 shares to a total of 26,259,647 shares, divided into
7,619,439 class A shares and 18,640,208 B shares. The directed share
issue will increase the share capital by 3,791,469 SEK, from 22,468,178
to 26,259,647 SEK and increases the number of voting rights from
9,104,313 to 9,483,460 votes. The acquisition: On December 7th, 2015
ADDvise signed a letter of intent to acquire LabRum AB. The Buyer\'s due
diligence is expected to be completed, the share purchase agreement
signed and the acquisition completed in early 2016. Financial advisor:
Mangold Fondkommission AB is financial advisor to ADDvise in connection
with the issue.
For further information, please contact:
Rikard Akhtarzand, CEO, +46 765-25 90 71
rikard.akhtarzand@addvisegroup.se
www.addvisegroup.com
About ADDvise Group AB
ADDvise Group AB (publ) is an expansive group which through its
subsidiaries IM-Medico Svenska AB, KEBO Inredningar Sverige AB, ADDvise
Tillquist AB, Sonesta Medical AB, Sonesta Medical Inc and Surgical
Tables Inc offers comprehensive solutions in the form of products and
services to healthcare and research facilities. ADDvise Group\'s
customers are located in both the private and public sectors. The
Company\'s share is listed on First North Premier and Mangold
Fondkommission AB, +46 8-503015 50, is the company\'s Certified Adviser
and liquidity provider.
